Your biology,
upgraded.

Growth hormone secretagogue that stimulates your pituitary to produce natural GH — without the risks of exogenous HGH. Targets anti-aging, body composition improvement, enhanced sleep quality, and metabolic function. Administered subcutaneously before sleep.

Combined GHRP + GHRH stack that produces sustained, pulsatile GH release. Clinically used for fat loss, lean muscle preservation, accelerated recovery, and improved sleep architecture. One of the most well-researched growth hormone protocols available.

Body Protection Compound derived from gastric juice proteins. Potent healing and anti-inflammatory activity — particularly effective for gut lining repair, tendon and ligament recovery, joint inflammation, and neurological tissue. Subject of ongoing reclassification by FDA.

Nicotinamide adenine dinucleotide — the coenzyme at the center of cellular energy metabolism. Supports mitochondrial function, DNA repair, sirtuin activation, cognitive clarity, and metabolic resilience. Available as IV, IM, or subcutaneous formulations.

Melanocortin receptor agonist that acts via the central nervous system — not vascular pathway. Addresses sexual dysfunction in both men and women by targeting the brain's arousal centers. FDA-approved analog exists (Vyleesi). Effective for HSDD and ED unresponsive to PDE5 inhibitors.

Naturally occurring copper-binding peptide with powerful regenerative properties. Stimulates collagen and elastin synthesis, accelerates wound healing, reduces inflammation, and activates tissue remodeling pathways. Used topically and systemically for anti-aging and recovery.

Actin-sequestering peptide with broad tissue regeneration properties. Reduces inflammation, promotes angiogenesis, improves flexibility, and accelerates healing of muscles, tendons, ligaments, and cardiac tissue. Widely used in performance recovery.

FDA-approved GHRH analog (Egrifta) shown to reduce visceral adipose tissue by 15–18% in clinical trials. Also demonstrated to improve cognitive function in older adults. Targets the GH/IGF-1 axis with high receptor specificity and a strong safety profile.

Tetrapeptide that activates telomerase and promotes telomere elongation — one of the few peptides with direct evidence of longevity mechanisms. Also regulates melatonin secretion and circadian rhythm. Developed at the St. Petersburg Institute of Bioregulation.

Human cathelicidin antimicrobial peptide with broad-spectrum antibacterial and antiviral activity. Modulates innate immune response, promotes wound healing, and has demonstrated activity against biofilm-forming pathogens. Under research for chronic infection and immune dysregulation.

Synthetic analogue of tuftsin with anxiolytic and nootropic properties. Reduces anxiety without sedation, enhances memory consolidation, and modulates IL-6/immune response. Registered as a pharmaceutical in Russia. Strong safety profile with no documented dependence.

ACTH-derived neuroprotective peptide that stimulates BDNF, NGF, and VEGF. Enhances working memory, focus, and neuroprotection under cognitive load. Registered pharmaceutical in Russia for stroke and TBI recovery. Administered intranasally.

Mitochondria-derived peptide that activates the AMPK pathway — the same pathway triggered by exercise. Improves insulin sensitivity, reduces visceral adipose tissue, and has demonstrated longevity signals in animal models. One of the most exciting emerging peptides in metabolic and anti-aging research. Pending FDA reclassification from Category 2 to Category 1.